Showing results (1711-1720 of 1,735) with videos related to

Sort By:
Pageof 174
Neuro-Oncology Practice|January 20, 2023
Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year periodPeter Y M Woo, Stephen Yau, Tai-Chung Lam, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2022
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue SarcomaSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
Frontiers in Immunology|June 19, 2025
Novel NUDCD1 gene variant predisposes to severe COVID-19 disease in Asians through modulation of antiviral DHX15- and MAVS-mediated signallingAseervatham Anusha Amali, Douglas Jie Wen Tay, Yiqi Seow, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Knowledge, Attitudes, and Practices of COVID-19 Vaccination among Adults in Singapore: A Cross-Sectional StudyJoseph Cheng Yuen Juin, Shaun Loong Seh Ern, Clare Elisabeth Ho Si Min, et al.
The Lancet. Oncology|December 16, 2019
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trialsRobert C Doebele, Alexander Drilon, Luis Paz-Ares, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 2, 2022
Biallelic variants in PIGN cause Fryns syndrome, multiple congenital anomalies-hypotonia-seizures syndrome, and neurologic phenotypes: A genotype-phenotype correlation studyLucy Loong, Agostina Tardivo, Alexej Knaus, et al.
The Lancet. Oncology|July 13, 2019
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trialSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 MutationsJames J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Nuclear regulatory disturbances precede and predict the development of Type-2 diabetes in Asian populationsPritesh R Jain, Hong Kiat Ng, Darwin Tay, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 14, 2022
The road to recovery: a synthesis of outcomes from ecosystem restoration in tropical and sub-tropical Asian forestsLindsay F Banin, Elizabeth H Raine, Lucy M Rowland, et al.
Pageof 174